Adelaide University bioethicists warn online health subscription risks as 11 million Australians used telehealth in 2025
Adelaide University and University of Wollongong bioethicists say Australia's commercial online health platforms can blur patient and customer roles, creating risks of fragmented care and inappropriate prescribing. The analysis arrives as more than 11 million Australians used telehealth in 2025 and a national safety body has been tasked with virtual-care standards. It matters because subscription platforms may reach people who cannot access a regular GP.
Adelaide University bioethicists, working with the University of Wollongong, said commercial online health platforms in Australia are creating patient-safety concerns by mixing subscription retail with medical care, according to research published in JME Practical Bioethics. The team analyzed the multibillion-dollar online commercial health platform sector and described services that market prescriptions for weight-loss injectables, hair-loss medications, peptides and testosterone treatments, often alongside supplements and membership plans.
The researchers pointed to 2025 data showing more than 11 million Australians had a telehealth consultation, while warning that these commercial platforms differ from ordinary telehealth provided by a GP or public health system. They said brief phone consults, online quizzes, unverified histories and limited use of My Health Record can increase the risk of fragmented care, inappropriate prescribing and missed information, especially for people with complex needs or multiple medications.
Lead researcher Hilary Bowman-Smart said the platforms respond to demand created by long waits and rising health-care costs, but convenience does not guarantee quality, appropriateness or affordability. She said subscription models can push doctors toward prescribing a platform's preferred solution and may reduce patients to forms and clicks, while clinicians may feel pressured to tick boxes. The Australian Commission on Safety and Quality in Health Care has been tasked with developing national safety and quality standards for virtual care.
The study is a bioethics and policy analysis, not a clinical trial or patient-outcome dataset, so it identifies structural risks rather than measuring harm rates. It can show how platform design, commercial incentives and weak integration with records may increase uncertainty about prescribing quality. The source did not list a funding source. Stronger evidence would require audits of consultations, adverse-event reporting, medication reconciliation rates and comparisons with in-person care under national virtual-care standards being developed.
People who use online subscription health services, especially those with complex medication needs, may face missed histories and pressure to receive marketed treatments. Clinicians and regulators are also affected because the sector is growing faster than oversight.
Sources (1)
- [1]Original source(https://medicalxpress.com/news/2026-11-prescription-subscription-hidden-online-health.html)